Department of Genetics
Yale School ofÂ Medicine, USA
Dr. Park received his BS and MS from Seoul National University at Korea and PhD from University of Illinois at UrbanaChampaign in the field of Cell and Structural Biology. During his PhD training he studied mTOR pathways regulating cell growth and myogenic differentiation. He continued his research as a Postdoc fellow in Dr. George Daley’s lab in Harvard Medical School where he isolated one of the first human induced pluripotent stem iPS cells and investigated the epigenetic change during reprogramming process. He is now an Assistant Professor of Genetics and Yale Stem Cell Center at Yale University.
Dr. Park have shown that the overexpression of genes important for pluripotent stem cells convert somatic cells to become induced pluripotent stem (iPS) cells that have similar features of embryonic stem cells. The iPS cells provide unprecedented resources for cell replacement therapy and for developing platforms for drug discovery. Dr. Park’s lab investigates the molecular and epigenetic mechanism of reprogramming and the utility of iPS cells for human diseases.